findmyKOL
Clinical trialNCT00193219CompletedPhase 2Interventional

Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer

SponsorSCRI Development Innovations, LLCEnrollment36Colon Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Oncology Hematology Associates of Sw Indiana

    Evansville, Indiana, United States

  • Consultants in Blood Disorders and Cancer

    Louisville, Kentucky, United States

  • Mercy Hospital

    Portland, Maine, United States

  • Center for Cancer and Blood Disorders

    Bethesda, Maryland, United States

  • Jackson Oncology Associates

    Jackson, Mississippi, United States

  • St. Louis Cancer Care

    Chesterfield, Missouri, United States

  • Methodist Cancer Center

    Omaha, Nebraska, United States

  • Oncology Hematology Care

    Cincinnati, Ohio, United States

  • Chattanooga Oncology and Hematology Associates

    Chattanooga, Tennessee, United States

  • Tennessee Oncology

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Fluorouracil →Bevacizumab →Cetuximab →Leucovorin →Oxaliplatin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2005
Primary completion
30 Jun 2008
Completion
31 Jul 2010
Last update posted
11 Jan 2022
Registered enrollment
36
Registry id
NCT00193219
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.